Back to Search Start Over

The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.

Authors :
Blankley S
Graham CM
Turner J
Berry MP
Bloom CI
Xu Z
Pascual V
Banchereau J
Chaussabel D
Breen R
Santis G
Blankenship DM
Lipman M
O'Garra A
Source :
PloS one [PLoS One] 2016 Oct 05; Vol. 11 (10), pp. e0162220. Date of Electronic Publication: 2016 Oct 05 (Print Publication: 2016).
Publication Year :
2016

Abstract

Background: Mycobacterium tuberculosis infection is a leading cause of infectious death worldwide. Gene-expression microarray studies profiling the blood transcriptional response of tuberculosis (TB) patients have been undertaken in order to better understand the host immune response as well as to identify potential biomarkers of disease. To date most of these studies have focused on pulmonary TB patients with gene-expression profiles of extra-pulmonary TB patients yet to be compared to those of patients with pulmonary TB or sarcoidosis.<br />Methods: A novel cohort of patients with extra-pulmonary TB and sarcoidosis was recruited and the transcriptional response of these patients compared to those with pulmonary TB using a variety of transcriptomic approaches including testing a previously defined 380 gene meta-signature of active TB.<br />Results: The 380 meta-signature broadly differentiated active TB from healthy controls in this new dataset consisting of pulmonary and extra-pulmonary TB. The top 15 genes from this meta-signature had a lower sensitivity for differentiating extra-pulmonary TB from healthy controls as compared to pulmonary TB. We found the blood transcriptional responses in pulmonary and extra-pulmonary TB to be heterogeneous and to reflect the extent of symptoms of disease.<br />Conclusions: The transcriptional signature in extra-pulmonary TB demonstrated heterogeneity of gene expression reflective of symptom status, while the signature of pulmonary TB was distinct, based on a higher proportion of symptomatic individuals. These findings are of importance for the rational design and implementation of mRNA based TB diagnostics.<br />Competing Interests: Patents have been filed against distinguishing active TB from latent TB and healthy controls, WO2009/158521, WO2011/066008; and active TB from sarcoidosis and other lung diseases (61/736,908t) (inventors, AOG, MPRB, CIB, JB, DC, VP). We confirm that this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Details

Language :
English
ISSN :
1932-6203
Volume :
11
Issue :
10
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
27706152
Full Text :
https://doi.org/10.1371/journal.pone.0162220